Bragg Financial Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.32M | Buy |
4,503
+3
| +0.1% | +$986 | 0.04% | 202 |
|
|
2025
Q4 | $1.58M | Hold |
4,500
| – | – | 0.05% | 196 |
|
|
2025
Q3 | $1.45M | Sell |
4,500
-31
| -0.7% | -$9.64K | 0.05% | 193 |
|
|
2025
Q2 | $1.76M | Buy |
4,531
+13
| +0.3% | +$5.23K | 0.06% | 190 |
|
|
2025
Q1 | $1.97M | Hold |
4,518
| – | – | 0.08% | 173 |
|
|
2024
Q4 | $1.67M | Hold |
4,518
| – | – | 0.07% | 182 |
|
|
2024
Q3 | $2.35M | Sell |
4,518
-48
| -1% | -$25.6K | 0.1% | 165 |
|
|
2024
Q2 | $2.47M | Sell |
4,566
-10
| -0.2% | -$5.29K | 0.11% | 153 |
|
|
2024
Q1 | $2.37M | Sell |
4,576
-20
| -0.4% | -$9.95K | 0.11% | 157 |
|
|
2023
Q4 | $2.17M | Hold |
4,596
| – | – | 0.1% | 158 |
|
|
2023
Q3 | $2M | Buy |
4,596
+66
| +1% | +$29.9K | 0.11% | 163 |
|
|
2023
Q2 | $2.01M | Hold |
4,530
| – | – | 0.11% | 158 |
|
|
2023
Q1 | $2.08M | Hold |
4,530
| – | – | 0.12% | 158 |
|
|
2022
Q4 | $2.32M | Hold |
4,530
| – | – | 0.14% | 154 |
|
|
2022
Q3 | $2.06M | Hold |
4,530
| – | – | 0.14% | 150 |
|
|
2022
Q2 | $2.19M | Hold |
4,530
| – | – | 0.15% | 144 |
|
|
2022
Q1 | $2.23M | Sell |
4,530
-1,802
| -28% | -$824K | 0.13% | 147 |
|
|
2021
Q4 | $2.36M | Hold |
6,332
| – | – | 0.15% | 139 |
|
|
2021
Q3 | $2.36M | Buy |
6,332
+32
| +0.5% | +$12.2K | 0.15% | 139 |
|
|
2021
Q2 | $2.4M | Hold |
6,300
| – | – | 0.15% | 139 |
|
|
2021
Q1 | $2.26M | Hold |
6,300
| – | – | 0.15% | 136 |
|
|
2020
Q4 | $2.02M | Hold |
6,300
| – | – | 0.18% | 133 |
|
|
2020
Q3 | $1.69M | Sell |
6,300
-26
| -0.4% | -$7K | 0.17% | 132 |
|
|
2020
Q2 | $1.66M | Sell |
6,326
-1,006
| -14% | -$268K | 0.19% | 131 |
|
|
2020
Q1 | $1.67M | Sell |
7,332
-23
| -0.3% | -$6.27K | 0.22% | 126 |
|
|
2019
Q4 | $2.22M | Hold |
7,355
| – | – | 0.25% | 123 |
|
|
2019
Q3 | $1.77M | Buy |
7,355
+14
| +0.2% | +$3.84K | 0.21% | 133 |
|
|
2019
Q2 | $2.07M | Buy |
7,341
+28
| +0.4% | +$7.65K | 0.26% | 125 |
|
|
2019
Q1 | $2.1M | Buy |
7,313
+13
| +0.2% | +$3.76K | 0.27% | 120 |
|
|
2018
Q4 | $1.92M | Hold |
7,300
| – | – | 0.29% | 117 |
|
|
2018
Q3 | $2M | Sell |
7,300
-40
| -0.5% | -$10.4K | 0.27% | 118 |
|
|
2018
Q2 | $1.75M | Hold |
7,340
| – | – | 0.25% | 125 |
|
|
2018
Q1 | $1.61M | Hold |
7,340
| – | – | 0.24% | 131 |
|
|
2017
Q4 | $1.65M | Hold |
7,340
| – | – | 0.24% | 129 |
|
|
2017
Q3 | $1.39M | Hold |
7,340
| – | – | 0.21% | 145 |
|
|
2017
Q2 | $1.38M | Hold |
7,340
| – | – | 0.22% | 142 |
|
|
2017
Q1 | $1.21M | Hold |
7,340
| – | – | 0.19% | 147 |
|
|
2016
Q4 | $1.05M | Hold |
7,340
| – | – | 0.17% | 162 |
|
|
2016
Q3 | $920K | Hold |
7,340
| – | – | 0.16% | 165 |
|
|
2016
Q2 | $964K | Sell |
7,340
-8
| -0.1% | -$1.09K | 0.17% | 162 |
|
|
2016
Q1 | $1.02M | Buy |
7,348
+3,048
| +71% | +$407K | 0.2% | 157 |
|
|
2015
Q4 | $600K | Hold |
4,300
| – | – | 0.13% | 173 |
|
|
2015
Q3 | $602K | Hold |
4,300
| – | – | 0.14% | 165 |
|
|
2015
Q2 | $706K | Hold |
4,300
| – | – | 0.16% | 163 |
|
|
2015
Q1 | $664K | Hold |
4,300
| – | – | 0.15% | 162 |
|
|
2014
Q4 | $553K | Buy |
+4,300
| New | +$531K | 0.13% | 170 |
|
|
2014
Q3 | – | Sell |
-4,300
| Closed | -$463K | – | 224 |
|
|
2014
Q2 | $463K | Hold |
4,300
| – | – | 0.11% | 185 |
|
|
2014
Q1 | $428K | Hold |
4,300
| – | – | 0.1% | 186 |
|
|
2013
Q4 | $397K | Buy |
+4,300
| New | +$382K | 0.1% | 196 |
|
Other funds holding ELV
VCM
VPM
Bragg Financial Advisors's ELV Position: Q1 2026 in Review
Bragg Financial Advisors increased its Elevance Health (ELV) stake by 0.07% in Q1 2026, buying an estimated $986 and bringing the position to 4,503 shares worth $1.32M. The position accounts for 0.04% of the portfolio, ranked #202.
Bragg Financial Advisors first reported a position in ELV in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.47M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Bragg Financial Advisors held 4,503 shares of Elevance Health worth $1.32M as of Q1 2026.
- Bragg Financial Advisors bought 3 Elevance Health shares in Q1 2026, an estimated $986.
- Elevance Health made up 0.04% of Bragg Financial Advisors's portfolio in Q1 2026, its #202 holding.
- Bragg Financial Advisors first reported a position in Elevance Health in Q4 2013 and has held it in 49 quarters since.
- Bragg Financial Advisors's Elevance Health position peaked at $2.47M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Bragg Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.